February 3-7, 2024
Boston Convention and Exhibition Center
Boston, MA, USA
February 3-7, 2024
Boston Convention and Exhibition Center
Boston, MA, USA
Chao Ma, New York University
Bioengineered Immunocompetent Human Leukemia Chip to Preclinically Screen CAR T-cell Immunotherapy
Yuka Otsuka, UF Scripps Biomedical Research
Midwest AViDD HTS for SARS2-CoV-2 Helicase Inhibitors
Elliott Leinauer, University of Missouri at Columbia
A Model of Regulated Secondary Flow for Circulating Tumor Cell Enrichment using Inertial Microfluidics
Nilmani Singh, University of Illinois at Urbana-Champaign
Continuous Protein Evolution Enabled by Machine Learning and Laboratory Automation
Peng Gao, NIH/NCATS
Deep Learning and Biochemical Cctivity-based Screening Strategy for Rapid Drug Discovery
Khashayar Moshksayan, University of Texas at Austin
OrganoidChip: An All-in-One Solution for Culturing and Blur-free Imaging of Intestinal Organoids
Annapoorna Ramasubramanya
One Health: A Machine Learning Approach Towards Environmental Understanding
Cayden Williamson, University of California Los Angeles
Hollow Microparticle-based Platform for the Screening of Millions of Colonies Producing Natural Products
Johnwon Lim, University of Illinois at Urbana-Champaign
Rapid and Ultra-sensitive Identification of Pathogenic DNA in Blood Using a Novel Blood Drying Technique
Flavio Bonanini, MIMETAS
An Automated and Multiplexed Liver Fibrosis Screening Assay on a Microfluidic Liver Model that Replicates the Cellular Composition and Organization of the Hepatic Lobule
Restuan Lubix, University of Duisburg-Essen
HTS-screening Technology Platform: 7 Helicases Inhibitors
Anna Popova, Karlsruhe Institute of Technology
Droplet Microarray (DMA) Chip for High Throughput Screening of Live Cells in Nano Scale: Use-cases for Novel Read-out Methods and Functional Personalized Oncology